Table 1.
Gender | ICU @ EoL | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Total | Male | Female | Yes | No | ||||||||
N (%) | 353 | 100.0% | 191 | 54.1% | 162 | 45.9% | 37 | 10.5% | 316 | 89.5% | ||
Characteristic | Mean | SD | Mean | SD | Mean | SD | P value | Mean | SD | Mean | SD | P value |
Age in years | 58.3 | 12.6 | 58.9 | 12.7 | 57.6 | 12.5 | 0.348 | 56.3 | 14.1 | 58.6 | 12.4 | 0.304 |
Education in years | 12.4 | 4.1 | 12.6 | 4.0 | 12.2 | 4.1 | 0.333 | 12.6 | 2.6 | 12.4 | 4.2 | 0.698 |
Karnofsky Performance Score | 63.9 | 15.6 | 62.2 | 15.0 | 65.8 | 16.0 | 0.028 | 62.0 | 10.5 | 64.1 | 16.0 | 0.308 |
Charlson Comobidity Index | 8.4 | 2.6 | 8.4 | 2.7 | 8.5 | 2.6 | 0.719 | 8.4 | 3.4 | 8.4 | 2.5 | 0.992 |
n | % | n | % | n | % | p | n | % | n | % | p | |
Male gender | 191 | 54.1% | 27 | 73.0% | 164 | 51.9% | 0.015 | |||||
Race/ethnicity | 0.201 | 0.142 | ||||||||||
White | 224 | 63.5% | 121 | 63.4% | 103 | 63.6% | 20 | 54.1% | 204 | 64.6% | ||
Black | 68 | 19.3% | 37 | 19.4% | 31 | 19.1% | 12 | 32.4% | 56 | 17.7% | ||
Hispanic | 56 | 15.9% | 28 | 14.7% | 28 | 17.3% | 4 | 10.8% | 52 | 16.5% | ||
Other | 5 | 1.4% | 5 | 2.6% | 0 | 0.0% | 1 | 2.7% | 4 | 1.3% | ||
Married | 190 | 54.8% | 121 | 64.4% | 69 | 43.4% | 0.000 | 24 | 64.9% | 166 | 53.5% | 0.191 |
Health Insurance | 198 | 57.4% | 108 | 58.4% | 90 | 56.3% | 0.690 | 22 | 61.1% | 176 | 57.0% | 0.633 |
Recruitment Site | 0.003 | 0.419 | ||||||||||
Yale Cancer Center | 76 | 21.7% | 43 | 22.6% | 33 | 20.5% | 8 | 21.6% | 68 | 21.7% | ||
West Haven VA Cancer Center | 16 | 4.6% | 16 | 8.4% | 0 | 0.0% | 0 | 0.0% | 16 | 5.1% | ||
Simmons Comprehensive Cancer Center | 35 | 10.0% | 13 | 6.8% | 22 | 13.7% | 2 | 5.4% | 33 | 10.5% | ||
Parkland Hospital | 154 | 43.9% | 81 | 42.6% | 73 | 45.3% | 16 | 43.2% | 138 | 43.9% | ||
Partners (DFCI, MGH) Cancer Centers | 9 | 2.6% | 4 | 2.1% | 5 | 3.1% | 1 | 2.7% | 8 | 2.5% | ||
New Hampshire Oncology-Hematology | 61 | 17.4% | 33 | 17.4% | 28 | 17.4% | 10 | 27.0% | 51 | 16.2% | ||
Type of Cancer | 0.000 | 0.543 | ||||||||||
Lung | 78 | 22.5% | 50 | 26.7% | 28 | 17.5% | 13 | 35.1% | 65 | 21.0% | ||
Colon | 45 | 13.0% | 27 | 14.4% | 18 | 11.3% | 4 | 10.8% | 41 | 13.2% | ||
Pancreatic | 28 | 8.1% | 13 | 7.0% | 15 | 9.4% | 3 | 8.1% | 25 | 8.1% | ||
Other Gastrointestinal | 44 | 12.7% | 30 | 16.0% | 14 | 8.8% | 4 | 10.8% | 40 | 12.9% | ||
Breast | 42 | 12.1% | 1 | 0.5% | 41 | 25.6% | 3 | 8.1% | 39 | 12.6% | ||
Other | 110 | 31.7% | 66 | 35.3% | 44 | 27.5% | 10 | 27.0% | 100 | 32.3% | ||
Do-Not-Resuscitate Order | 147 | 41.6% | 70 | 36.6% | 77 | 47.5% | 0.039 | 10 | 27.0% | 137 | 43.4% | 0.057 |
Preference for Palliative EOL care | 225 | 63.7% | 111 | 58.1% | 114 | 70.4% | 0.017 | 13 | 35.1% | 212 | 67.1% | 0.000 |
EOL Discussion | 128 | 36.3% | 68 | 35.6% | 60 | 37.0% | 0.780 | 7 | 18.9% | 121 | 38.3% | 0.020 |
Variables missing data: Karnofsky (5), Charlson (6), Married (6), Health Insurance (8), Recruitment Site (2), Cancer Diagnosis (6).